Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 58.56% is 31% below its 5-year average of 84.80%, around the middle of its 5-year range (9.98%–88.87%).
0.31% below its 12-month average of 58.74%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 62.77%.
GROSS MARGIN
58.56%
GROSS MARGIN AVG TTM
58.74%
GROSS MARGIN AVG 3Y
80.47%
GROSS MARGIN AVG 5Y
84.80%
GROSS MARGIN AVG 10Y
86.30%
GROSS MARGIN AVG 15Y
66.38%
GROSS MARGIN AVG 20Y
68.38%
CURRENT VS TTM AVG
-0.31%
CURRENT VS 3Y AVG
-27.23%
CURRENT VS 5Y AVG
-30.95%
CURRENT VS 10Y AVG
-32.14%
CURRENT VS 15Y AVG
-11.78%
CURRENT VS 20Y AVG
-14.36%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+41.52%
vs the sector median at left
Sarepta Therapeutics, Inc.
Market Cap
$1.81B
Gross Margin
58.56%
TTM Avg
58.74%
3Y Avg
80.47%
5Y Avg
84.80%
Market Cap
$1.81B
Gross Margin
72.90%
TTM Avg
70.08%
3Y Avg
67.68%
5Y Avg
66.96%
Market Cap
$1.84B
Gross Margin
9.22%
TTM Avg
11.32%
3Y Avg
13.89%
5Y Avg
14.07%
Market Cap
$1.85B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
22.32%
5Y Avg
30.29%
Market Cap
$1.77B
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | $1.81B | 58.56% | 58.74% | 80.47% | 84.80% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 72.90% | 70.08% | 67.68% | 66.96% |
| Azenta, Inc. (AZTA)vs › | $1.82B | 44.05% | 44.96% | 41.63% | 40.93% |
| Novavax, Inc. (NVAX)vs › | $1.82B | 93.67% | 81.97% | 61.43% | 74.28% |
| Xencor, Inc. (XNCR)vs › | $1.79B | 91.63% | -7.22% | 16.08% | 9.32% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 9.22% | 11.32% | 13.89% | 14.07% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.85B | 0.00% | 0.00% | 22.32% | 30.29% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | 100.00% | 100.00% | 100.00% | 100.00% |
| Immunome, Inc. (IMNM)vs › | $1.84B | 57.43% | 78.72% | 64.36% | 42.91% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 21.37% | 23.53% | 23.33% | 22.63% |
Gross Margin
58.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 62.77% |
| 2026-03-31 | 83.67% |
| 2025-12-31 | 9.98% |
| 2025-09-30 | 62.25% |
| 2025-06-30 | 75.04% |
| 2025-03-31 | 81.53% |
| 2024-12-31 | 79.91% |
| 2024-09-30 | 80.37% |
| 2024-06-30 | 87.73% |
| 2024-03-31 | 87.77% |
| 2023-12-31 | 88.87% |
| 2023-09-30 | 88.84% |
| 2023-06-30 | 86.94% |
| 2023-03-31 | 86.19% |
| 2022-12-31 | 88.08% |
| 2022-09-30 | 82.65% |
| 2022-06-30 | 83.81% |
| 2022-03-31 | 85.09% |
| 2021-12-31 | 84.24% |
| 2021-09-30 | 87.62% |
| 2021-06-30 | 88.11% |
| 2021-03-31 | 84.79% |
| 2020-12-31 | 84.56% |
| 2020-09-30 | 89.57% |
| 2020-06-30 | 90.29% |
| 2020-03-31 | 88.90% |
| 2019-12-31 | 84.45% |
| 2019-09-30 | 86.84% |
| 2019-06-30 | 83.18% |
| 2019-03-31 | 86.14% |
| 2018-12-31 | 84.44% |
| 2018-09-30 | 88.86% |
| 2018-06-30 | 90.84% |
| 2018-03-31 | 91.36% |
| 2017-12-31 | 93.81% |
| 2017-09-30 | 93.30% |
| 2017-06-30 | 98.47% |
| 2017-03-31 | 98.46% |
| 2016-12-31 | 97.60% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -3186.43% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | -113618.52% |
| 2014-09-30 | -3079.89% |
| 2014-06-30 | -1071.93% |
| 2014-03-31 | -312.63% |
| 2013-12-31 | -820.11% |
| 2013-09-30 | -498.20% |
| 2013-06-30 | -479.02% |
| 2013-03-31 | -200.89% |
| 2012-12-31 | -73.58% |
| 2012-09-30 | 8.83% |
| 2012-06-30 | 50.41% |
| 2012-03-31 | 38.69% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | -49.80% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 61.31% |
| 2010-12-31 | -76.95% |
| 2010-09-30 | 56.37% |
| 2010-06-30 | -91.82% |
| 2010-03-31 | -541.91% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 53.95% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
